The North Shore-LIJ Health System’s Feinstein Institute for Medical Research in Manhasset Thursday received a $250,000 research grant for the study of chronic lymphocytic leukemia and other blood cancers.
The two-year grant from the non-profit Lymphoma Research Foundation was awarded to Dr. Nicholas Chiorazzi, the head of the Institute’s Karches Center for Chronic Lymphocytic Leukemia Research, according to a press release issued by the North Shore-LIJ Health System.
Chiorazzi and his research partner, Dr. Matthew D. Scharff of the Albert Einstein College of Medicine in the Bronx, will use the grant to research gene expression and DNA methylation signatures linked to in vivo chronic lymphocytic leukemia/small lymphoctyic lymphoma B-cell kinetics and outcome, according to the release.
“I am grateful to the Lymphoma Research Foundation for supporting this research so that Dr. Scharff and I can work to better understand CLL and ultimately find a new, improved treatment for the devastating disease,” Chiorazzi said in the release.
According to a hospital release, the grant is part of a $2.15 million grant from the Lymphoma Research Foundation that has been divided among seven scientists.
Recommendations for the grant’s recipients were made by the foundation’s Scientific Advisory Board, made up of leading lymphoma researchers and oncologists, then approved by the foundation’s board of directors.
The Lymphoma Research Foundation, which based in Manhattan, has donated $54 million in lymphoma-specific research, according to the release.
“As evident in our recent funding of more than $2 million in research, the Lymphoma Research Foundation is dedicated to finding a cure for lymphoma through an aggressively funded research program,” said Diane Blum, the Lymphoma Research Foundation’s chief executive officer, in the release. “We remain grateful to our supporters whose generosity enables the Foundation to work toward its mission of eradicating lymphoma through innovative research.”
